Literature DB >> 9709308

Novel organizational features, captured cellular genes, and strain variability within the genome of KSHV/HHV8.

J Nicholas1, J C Zong, D J Alcendor, D M Ciufo, L J Poole, R T Sarisky, C J Chiou, X Zhang, X Wan, H G Guo, M S Reitz, G S Hayward.   

Abstract

Strong serologic and molecular probe correlations indicate that the newly discovered gamma herpesvirus KSHV or HHV8 is the likely etiologic agent of all forms of Kaposi's sarcoma as well as BCBL/PEL and MCD in patients with acquired immunodeficiency syndrome (AIDS). Two large segments of HHV8 DNA from an AIDS-associated BCBL tumor covering genomic positions 0-52 kilobase [kb] and 108-140 kb have been cloned, mapped, and partially sequenced. Our studies have focused on novel viral proteins encoded within a 13-kb divergent locus (DL-B) by nine captured homologues of cellular genes, including vIL-6, vDHFR, vTS, vBcl-2, three C-C beta chemokines (vMIP-1A, vMIP-1B, and vBCK), and two LAP/PHD subclass zinc finger proteins (IE1A and IE1B). The HHV-8 vIL-6, vDHFR, vTS, and vBcl-2 proteins have all been shown to be active in a variety of appropriate functional assays, and transcripts from vIL-6, vMIP-1B, vIE1-A, vIE1-B, and vDHFR genes are all expressed as abundant single messenger RNA species after butyrate or phorbol ester (TPA) induction of the lytic cycle in HHV8-positive BCBL cell lines. All of these genes lie within a divergent transcriptional domain that contains a single central enhancer and associated untranslated leader region plus seven distinct proximal promoters, some of which are negatively regulated through AP-1 and ZRE motifs by the EBV ZTA transactivator. This region also encompasses a predicted complex oriLyt domain of 1050 bp that is duplicated in inverted orientation adjacent to the T0.7 latency RNA in another large divergent locus (DL-E). We have previously described three distinct subtypes of the HHV8 genome that differ by 1.0%-1.5% at the nucleotide level within the ORF26 and ORF75 genes. Certain strains or clades appear to have preferential geographic distributions, but it is not known as yet whether there are any specific disease associations. Interestingly, the A, B, and C subtypes of HHV-8 also proved to differ dramatically in coding content at both the extreme left and right ends of the unique segment of the genome as well as in the positions of the junctions with the terminal repeats. On the left-hand side, the receptor-like ORF-K1 protein is highly variable with A-strain subtypes displaying 15% amino acid differences from C strains and up to 30% differences from B strains. On the right-hand side, two unrelated alternative types of the putative multiple membrane spanning ORF-K15 protein are found.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9709308     DOI: 10.1093/oxfordjournals.jncimonographs.a024179

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN: 1052-6773


  61 in total

1.  Identification of human herpesvirus 8-specific cytotoxic T-cell responses.

Authors:  M Osman; T Kubo; J Gill; F Neipel; M Becker; G Smith; R Weiss; B Gazzard; C Boshoff; F Gotch
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Characterization of two divergent lineages of macaque rhadinoviruses related to Kaposi's sarcoma-associated herpesvirus.

Authors:  E R Schultz; G W Rankin; M P Blanc; B W Raden; C C Tsai; T M Rose
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 3.  Signaling activities of gammaherpesvirus membrane proteins.

Authors:  B Damania; J K Choi; J U Jung
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Two distinct gamma-2 herpesviruses in African green monkeys: a second gamma-2 herpesvirus lineage among old world primates?

Authors:  J Greensill; J A Sheldon; N M Renwick; B E Beer; S Norley; J Goudsmit; T F Schulz
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations.

Authors:  J C Zong; D M Ciufo; D J Alcendor; X Wan; J Nicholas; P J Browning; P L Rady; S K Tyring; J M Orenstein; C S Rabkin; I J Su; K F Powell; M Croxson; K E Foreman; B J Nickoloff; S Alkan; G S Hayward
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 6.  Evolutionary aspects of oncogenic herpesviruses.

Authors:  J Nicholas
Journal:  Mol Pathol       Date:  2000-10

7.  Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures.

Authors:  D M Ciufo; J S Cannon; L J Poole; F Y Wu; P Murray; R F Ambinder; G S Hayward
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

8.  Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: cis-acting requirements for replication and ori-Lyt-associated RNA transcription.

Authors:  Yan Wang; Hong Li; Man Yee Chan; Fan Xiu Zhu; David M Lukac; Yan Yuan
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  Model-based inference of recombination hotspots in a highly variable oncogene [corrected].

Authors:  G Greenspan; D Geiger; F Gotch; M Bower; S Patterson; M Nelson; B Gazzard; J Stebbing
Journal:  J Mol Evol       Date:  2004-03       Impact factor: 2.395

10.  Characterization of human herpes virus 8 genotypes in Kaposi's sarcoma patients in Tehran, Iran.

Authors:  Kayhan Azadmanesh; Zeinab Sadat Norouzfar; Amir Sohrabi; Zahra Safaie-Naraghi; Afshin Moradi; Parichehre Yaghmaei; Mona Masoumeh Naraghi; Arash Arashkia; Ali Eslamifar
Journal:  Int J Mol Epidemiol Genet       Date:  2012-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.